Multinational corporations, the state, and contemporary medicine

Abstract

In this paper we explore the ways in which corporations have become powerful actors in the political and economic landscapes, and the role the state has played in this development. Focusing on the pharmaceutical industry, we find that revolving door practices have been a key instrument in furthering the growth of corporate power, leading us to a reconsideration of the concepts of class struggle and the role of the state in the maintenance of the dominant class’ privileges. We conclude that our findings lend support to Harvey’s theory of neoliberalism as a specific project to restore power to the dominant class, and also to Marx’s conception of state power subordinated to capitalist economic power.